Clinical Trials
6 trialsNCT03740165 2026-05-04
KEYLYNK-001
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT06888921 2026-04-01
MAIA-ovarian
Compugen Ltd
Phase 1/2 Recruiting
NCT05116189 2026-03-09
KEYNOTE-B96
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT03635567 2026-02-04
KEYNOTE-826
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT05794659 2023-07-20
Cornerstone4
Aston Sci. Inc.
Phase 2 Not yet recruiting
NCT00738699 2017-03-30
FAR-122
Morphotek
Phase 2 Terminated